Maze Therapeutics, Inc.
MAZE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | $52,231 | -$100,415 | -$114,940 |
| Dep. & Amort. | $3,297 | $4,089 | $3,820 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $9,646 | $8,747 | $6,736 |
| Change in WC | -$1,523 | -$6,316 | -$3,236 |
| Other Non-Cash | $12,303 | $7,068 | $8,417 |
| Operating Cash Flow | $75,954 | -$86,827 | -$99,203 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$1,147 | -$441 | -$1,966 |
| Net Acquisitions | $0 | $0 | -$1,204 |
| Inv. Purchases | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 |
| Investing Cash Flow | -$1,147 | -$441 | -$3,170 |
| Financing Activities | – | – | – |
| Debt Repay. | $24,475 | $16,176 | $0 |
| Stock Issued | $68,372 | $209 | $1,728 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 |
| Financing Cash Flow | $92,847 | $16,385 | $1,728 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | $167,654 | -$70,883 | -$100,645 |
| Supplemental Information | – | – | – |
| Beg. Cash | $30,246 | $101,129 | $201,774 |
| End Cash | $197,900 | $30,246 | $101,129 |
| Free Cash Flow | $74,807 | -$87,268 | -$101,169 |